Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer

BACKGROUND AND PURPOSE: Patients with locally advanced oropharynx squamous cell carcinoma have suboptimal outcomes with standard chemoradiation. Here, we evaluated toxicity and oncologic outcomes of dose escalation using radiosurgical boost for patients with unfavorable oropharynx squamous cell carc...

Descripción completa

Detalles Bibliográficos
Autores principales: Vempati, Prashant, Halthore, Aditya N., Teckie, Sewit, Rana, Zaker, Gogineni, Emile, Antone, Jeffrey, Zhang, Honglai, Marrero, Mihaela, Beadle, Kristin, Frank, Douglas K., Aziz, Mohamed, Paul, Doru, Ghaly, Maged
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731764/
https://www.ncbi.nlm.nih.gov/pubmed/33308265
http://dx.doi.org/10.1186/s13014-020-01718-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731764/
https://www.ncbi.nlm.nih.gov/pubmed/33308265
http://dx.doi.org/10.1186/s13014-020-01718-w

Ejemplares similares